These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27338974)

  • 21. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity.
    Rogers SC; Pruitt CW; Crouch DJ; Caravati EM
    Pediatr Emerg Care; 2010 Sep; 26(9):665-6. PubMed ID: 20838187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focus on alcohol & drug abuse: ensuring validity in urine drug testing.
    Jaffee WB; Trucco E; Teter C; Levy S; Weiss RD
    Psychiatr Serv; 2008 Feb; 59(2):140-2. PubMed ID: 18245154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups.
    Lin CN; Nelson GJ; McMillin GA
    J Anal Toxicol; 2013; 37(1):30-6. PubMed ID: 23144203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug of abuse screening in urine in emergency situations; useful or not?].
    De Wit LE; Dekker D
    Ned Tijdschr Geneeskd; 2021 Feb; 164():. PubMed ID: 33651500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions.
    Denis C; Fatséas M; Beltran V; Bonnet C; Picard S; Combourieu I; Daulouède JP; Auriacombe M
    Subst Use Misuse; 2012 Mar; 47(4):356-63. PubMed ID: 22216906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of drug use during pregnancy.
    Kwong TC; Shearer D
    Obstet Gynecol Clin North Am; 1998 Mar; 25(1):43-64. PubMed ID: 9547759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance Abuse Surveillance Among Construction Workers: A Proof of Concept Alternative Approach.
    Caban-Martinez AJ; Sierra D; Ruano-Herreria EC; Reidy LJ
    J Occup Environ Med; 2018 Mar; 60(3):e157-e158. PubMed ID: 29303868
    [No Abstract]   [Full Text] [Related]  

  • 30. Validation of the Drug Abuse Screening Test (DAST-10): A study on illicit drug use among Chinese pregnant women.
    Lam LP; Leung WC; Ip P; Chow CB; Chan MF; Ng JW; Sing C; Lam YH; Mak WL; Chow KM; Chin RK
    Sci Rep; 2015 Jun; 5():11420. PubMed ID: 26091290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine adulterant test for oxidants yields positive results from microbial-contaminated urine.
    Brazwell E; Crossey M; Racz M; Quitoriano T; Chavez M
    J Anal Toxicol; 2004; 28(8):692-3. PubMed ID: 15586447
    [No Abstract]   [Full Text] [Related]  

  • 32. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of saliva testing to urinalysis in an arrestee population.
    Yacoubian GS; Wish ED; Pérez DM
    J Psychoactive Drugs; 2001; 33(3):289-94. PubMed ID: 11718322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European guidelines for workplace drug testing in urine.
    Taskinen S; Beck O; Bosch T; Brcak M; Carmichael D; Fucci N; George C; Piper M; Salomone A; Schielen W; Steinmeyer S; Weinmann W
    Drug Test Anal; 2017 Jun; 9(6):853-865. PubMed ID: 28267298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 36. Do rapid comprehensive urine drug screens change clinical management in children?
    Christian MR; Lowry JA; Algren DA; Thornton SL; Deng S; Garg U
    Clin Toxicol (Phila); 2017 Nov; 55(9):977-980. PubMed ID: 28594290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underreporting of illicit drug use by patients at emergency departments as revealed by two-tiered urinalysis.
    Chen WJ; Fang CC; Shyu RS; Lin KC
    Addict Behav; 2006 Dec; 31(12):2304-8. PubMed ID: 16564643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpretation of urine drug testing in pain patients.
    Pesce A; West C; Egan City K; Strickland J
    Pain Med; 2012 Jul; 13(7):868-85. PubMed ID: 22494459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and preliminary validation of an indirect screener for drug use in the perinatal period.
    Ondersma SJ; Svikis DS; LeBreton JM; Streiner DL; Grekin ER; Lam PK; Connors-Burge V
    Addiction; 2012 Dec; 107(12):2099-106. PubMed ID: 22882721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A procedure for the detection of Stealth adulterant in urine samples.
    Valtier S; Cody JT
    Clin Lab Sci; 2002; 15(2):111-5. PubMed ID: 12776774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.